אודנטרון

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

ONDANSETRON AS HYDROCHLORIDE DIHYDRATE

Disponible desde:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

Código ATC:

A04AA01

formulario farmacéutico:

תמיסה להזרקה

Composición:

ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 2 MG/ML

Vía de administración:

תוך-ורידי, תוך-שרירי

tipo de receta:

מרשם נדרש

Fabricado por:

KLEVA S.A., GREECE

Grupo terapéutico:

ONDANSETRON

Área terapéutica:

ONDANSETRON

indicaciones terapéuticas:

Adults: Odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV).Paediatric Population: Odantron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ?6 months, and for the prevention and treatment of PONV in children aged ?2 years.

Fecha de autorización:

2018-07-31